Barclays lowered the firm’s price target on Varonis (VRNS) to $50 from $70 and keeps an Overweight rating on the shares. The company missed annual recurring revenue estimates in Q3 and its lowered its fiscal 2025 ARR guidance on a softer U.S. federal environment and higher churn in on-premise, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNS:
- Varonis Systems: Buy Rating Affirmed Amid SaaS Growth and Strategic Adjustments
- Varonis Systems Reports Strong SaaS Growth Amid Strategic Shifts
- Closing Bell Movers: Bloom Energy, Teradyne both up 20% on earnings
- Varonis down 30% at $44.11 after Q3 results and guidance
- Varonis announces new $150M buyback